We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
+4.27%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$56.6B
AUM Growth
-$4.33B
(-7.1%)
Cap. Flow
-$5.51B
Cap. Flow
% of AUM
-9.73%
Top 10 Holdings %
Top 10 Hldgs %
36.93%
Holding
1,739
New
42
Increased
177
Reduced
1,384
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$201M |
| 2 |
Oracle
ORCL
|
+$135M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$123M |
| 4 |
Invesco MSCI USA ETF
PBUS
|
+$80.7M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$63M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$267M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$183M |
| 3 |
NVIDIA
NVDA
|
+$172M |
| 4 |
JPMorgan Chase
JPM
|
+$137M |
| 5 |
Apple
AAPL
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.12% |
| 2 | Financials | 12.63% |
| 3 | Healthcare | 12.38% |
| 4 | Communication Services | 10.27% |
| 5 | Consumer Discretionary | 9.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
American Financial Group
AFG
$11.9B
| $464K | ﹤0.01% |
3,396
-6,600
| -66% | -$906K |
|
977
Cytokinetics
CYTK
$10.7B
| $464K | ﹤0.01% |
7,296
-13,200
| -64% | -$821K |
|
978
Landstar System
LSTR
$6.01B
| $463K | ﹤0.01% |
3,221
-2,495
| -44% | -$332K |
|
979
iShares MSCI Qatar ETF
QAT
$63.8M
| $463K | ﹤0.01% |
+24,580
| New | +$469K |
|
980
iShares MSCI Kuwait ETF
KWT
$71.4M
| $458K | ﹤0.01% |
+11,960
| New | +$472K |
|
981
Madison Square Garden
MSGS
$9.59B
| $453K | ﹤0.01% |
1,750
-950
| -35% | -$216K |
|
982
Lantheus
LNTH
$6.51B
| $452K | ﹤0.01% |
6,799
-39,263
| -85% | -$2.28M |
|
983
Valley National Bancorp
VLY
$7.94B
| $447K | ﹤0.01% |
38,246
-96,415
| -72% | -$1.07M |
|
984
Regal Rexnord
RRX
$12.8B
| $447K | ﹤0.01% |
3,183
-6,650
| -68% | -$946K |
|
985
Hess Midstream
HESM
$5.19B
| $446K | ﹤0.01% |
12,920
| – | – |
|
986
SiTime
SITM
$14.1B
| $443K | ﹤0.01% |
1,254
-2,300
| -65% | -$720K |
|
987
Avantor
AVTR
$9.72B
| $442K | ﹤0.01% |
38,546
-100,350
| -72% | -$1.24M |
|
988
Onto Innovation
ONTO
$10.9B
| $440K | ﹤0.01% |
2,789
-5,050
| -64% | -$717K |
|
989
Atlanta Braves Holdings Series A
BATRA
$3.5B
| $440K | ﹤0.01% |
10,359
-1,400
| -12% | -$60.2K |
|
990
Viper Energy
VNOM
$8.42B
| $440K | ﹤0.01% |
11,388
-18,450
| -62% | -$699K |
|
991
Interparfums
IPAR
$4.04B
| $439K | ﹤0.01% |
5,178
-1,700
| -25% | -$150K |
|
992
Elastic
ESTC
$6.75B
| $434K | ﹤0.01% |
5,751
-16,745
| -74% | -$1.37M |
|
993
Cleveland-Cliffs
CLF
$6.46B
| $433K | ﹤0.01% |
32,575
-56,650
| -63% | -$715K |
|
994
UiPath
PATH
$6.52B
| $431K | ﹤0.01% |
26,278
-62,600
| -70% | -$974K |
|
995
Lumen
LUMN
$6.36B
| $428K | ﹤0.01% |
55,050
-122,150
| -69% | -$1.01M |
|
996
Bio-Rad Laboratories Class A
BIO
$8.76B
| $423K | ﹤0.01% |
1,395
-3,550
| -72% | -$1.11M |
|
997
Pinnacle West Capital
PNW
$12.5B
| $421K | ﹤0.01% |
4,746
-8,450
| -64% | -$757K |
|
998
Hancock Whitney
HWC
$6.2B
| $418K | ﹤0.01% |
6,570
-14,470
| -69% | -$879K |
|
999
Primerica
PRI
$10.1B
| $418K | ﹤0.01% |
1,617
-3,300
| -67% | -$861K |
|
1000
Healthcare Realty
HR
$7.55B
| $418K | ﹤0.01% |
24,644
-37,250
| -60% | -$663K |
|
Similar funds
SCP
Ensign Peak Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Ensign Peak Advisors held 1,739 positions worth $56.6B, down 7.1% from $60.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Ensign Peak Advisors withdrew a net $5.51B in Q4 2025, closing 54 positions and reducing 1,384 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $125M position sold in full.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Ensign Peak Advisors opened a new position in Invesco MSCI USA ETF worth $81.3M.
- Ensign Peak Advisors's largest Q4 2025 buy was Invesco MSCI USA ETF: 1,188,232 shares worth $81.3M.
- Ensign Peak Advisors added most to Eli Lilly in Q4 2025, an estimated $201M increase.
- Ensign Peak Advisors's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $267M.
- Ensign Peak Advisors fully exited iShares Core S&P 500 ETF in Q4 2025, selling an estimated $125M.
- Ensign Peak Advisors's ten largest holdings make up 37% of its $56.6B portfolio in Q4 2025.
- Ensign Peak Advisors opened 42 new positions and closed 54 in Q4 2025.
- Ensign Peak Advisors's portfolio value fell 7.1% quarter-over-quarter to $56.6B.
Based on Ensign Peak Advisors's 13F filing for Q4 2025, filed 12 Feb 2026.